# Itch and Pain Behaviors in Irritant Contact Dermatitis Produced by Sodium Lauryl Sulfate in Mice

**Authors:** Nathalie M. Malewicz-Oeck, Zhe Zhang, Steven G. Shimada, Robert H. LaMotte

PMC · DOI: 10.3390/ijms25147718 · International Journal of Molecular Sciences · 2024-07-14

## TL;DR

This study shows that sodium lauryl sulfate causes skin inflammation in mice, leading to pain and itching behaviors that appear before the peak of inflammation.

## Contribution

The study identifies distinct pain and itch behaviors in irritant contact dermatitis and their temporal relationship to inflammation.

## Key findings

- SLS-treated mice showed hyperalgesia to mechanical and heat stimuli on day 1.
- Pruritogen injections increased scratching but not wiping in SLS-treated mice.
- Skin inflammation peaked on days 1 and 2 with erythema, scaling, and increased thickness.

## Abstract

Irritant contact dermatitis (ICD) is a nonspecific skin inflammation caused by irritants, leading to itch and pain. We tested whether differential responses to histamine-dependent and -independent pruritogens can be evoked in ICD induced by sodium lauryl sulfate (SLS). An ICD mouse model was established with 5% SLS in acetone versus a vehicle topically applied for 24 h to the cheek. Site-directed itch- and pain-like behaviors, occurring spontaneously and in response to mechanical, thermal, and chemical stimuli (histamine, ß-alanine, BAM8-22, and bradykinin) applied to the cheek, were recorded before (day 0) and after irritant removal (days 1, 2, 3, and 4). Skin inflammation was assessed through visual scoring, ultrasound, and measurements of skin thickness. SLS-treated mice exhibited hyperalgesia-like behavior in response to mechanical and heat stimuli on day 1 compared to the controls. SLS mice exhibited more spontaneous wipes (pain) but not scratching bouts (itch) on day 1. Pruritogen injections caused more scratching but not wiping in SLS-treated mice compared to the controls. Only bradykinin increased wiping behavior compared to saline. SLS-treated mice developed noticeable erythema, scaling, and increased skin thickness on days 1 and 2. SLS induced cutaneous inflammation and behavioral signs of spontaneous pain and itching, hyperalgesia to mechanical and heat stimuli and a chemical algogen, and enhanced itch response to pruritogens. These sensory reactions preceded the inflammation peak and lasted up to two days.

## Linked entities

- **Chemicals:** sodium lauryl sulfate (PubChem CID 3423265), histamine (PubChem CID 774), ß-alanine (PubChem CID 239), BAM8-22 (PubChem CID 16158367), bradykinin (PubChem CID 439201)
- **Diseases:** irritant contact dermatitis (MONDO:0006564)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** erythema (MESH:D004890), Itch (MESH:D011537), hyperalgesia (MESH:D006930), Skin inflammation (MESH:D007249), Pain (MESH:D010146), ICD (MESH:D003877)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11276812/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11276812/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC11276812/full.md

---
Source: https://tomesphere.com/paper/PMC11276812